[go: up one dir, main page]

DK0482013T3 - Ikke-glycolyserede humant interleukin-3 analoge proteiner - Google Patents

Ikke-glycolyserede humant interleukin-3 analoge proteiner

Info

Publication number
DK0482013T3
DK0482013T3 DK90909318.9T DK90909318T DK0482013T3 DK 0482013 T3 DK0482013 T3 DK 0482013T3 DK 90909318 T DK90909318 T DK 90909318T DK 0482013 T3 DK0482013 T3 DK 0482013T3
Authority
DK
Denmark
Prior art keywords
glycolysed
human interleukin
analog proteins
analog
proteins
Prior art date
Application number
DK90909318.9T
Other languages
Danish (da)
English (en)
Inventor
David L Urdal
Helmut Sassenfeld
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of DK0482013T3 publication Critical patent/DK0482013T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/823—Lower fungi, e.g. mold
    • Y10S530/824—Yeasts
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/141—Interleukin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK90909318.9T 1989-06-30 1990-06-13 Ikke-glycolyserede humant interleukin-3 analoge proteiner DK0482013T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/374,667 US5128450A (en) 1989-06-30 1989-06-30 Nonglycosylated human interleukin-3 analog proteins

Publications (1)

Publication Number Publication Date
DK0482013T3 true DK0482013T3 (da) 1996-06-03

Family

ID=23477728

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90909318.9T DK0482013T3 (da) 1989-06-30 1990-06-13 Ikke-glycolyserede humant interleukin-3 analoge proteiner

Country Status (12)

Country Link
US (1) US5128450A (fr)
EP (1) EP0482013B1 (fr)
JP (1) JPH04506342A (fr)
AT (1) ATE138099T1 (fr)
AU (1) AU630207B2 (fr)
CA (1) CA2033182A1 (fr)
DE (1) DE69027031T2 (fr)
DK (1) DK0482013T3 (fr)
ES (1) ES2090135T3 (fr)
FI (1) FI916077A7 (fr)
NO (1) NO301482B1 (fr)
WO (1) WO1991000350A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328988A (en) * 1987-10-26 1994-07-12 Immunex Corporation Interleukin-7
US5714585A (en) * 1987-10-26 1998-02-03 Sterling Winthrop, Inc. Antibodies that are immunoreactive with interleukin-7
US5705362A (en) * 1992-05-25 1998-01-06 Gist-Brocades, N.V. Modified signal sequences
US5463029A (en) * 1992-11-23 1995-10-31 Immunex Corporation Purification of fusion proteins comprising GM-CSF and IL-3
US6361976B1 (en) 1992-11-24 2002-03-26 S. Christopher Bauer Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production
US5772992A (en) * 1992-11-24 1998-06-30 G.D. Searle & Co. Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US6403076B1 (en) 1992-11-24 2002-06-11 S. Christopher Bauer Compositions for increasing hematopoiesis with interleukin-3 mutants
US6153183A (en) * 1992-11-24 2000-11-28 G. D. Searle & Company Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production
CA2150117A1 (fr) * 1992-11-24 1994-06-09 S. Christopher Bauer Polypeptides mutants de l'interleukine 3 (il-3)
US5501962A (en) * 1993-06-21 1996-03-26 G. D. Searle & Co. Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same
WO1995013089A1 (fr) * 1993-11-10 1995-05-18 Henry M. Jackson Foundation For The Advancement Of Military Medicine Compositions et procede de stimulation de la liberation d'anticorps par les lymphocytes b
US6017523A (en) * 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
CN100374163C (zh) 1999-01-13 2008-03-12 阿尔凯米亚肿瘤学私人有限公司 增强药物功效的组合物
US9066919B2 (en) * 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
AUPQ879500A0 (en) * 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
AU2002244247B2 (en) 2001-03-01 2007-12-13 Harbor Biosciences, Inc. Use of certain steroids for treatment of blood cell deficiencies
WO2003018062A1 (fr) * 2001-08-27 2003-03-06 Meditech Research Limited Protocoles therapeutiques ameliores
JP4212827B2 (ja) * 2002-05-16 2009-01-21 シスメックス株式会社 骨髄液有核細胞自動分析方法
EP2298316A1 (fr) 2002-08-28 2011-03-23 Harbor BioSciences, Inc. Procedes de traitement therapeutique
EP1848738A1 (fr) * 2005-01-25 2007-10-31 Apollo Life Sciences Limited Gm-csf, il-3, il-4, il-5 choisis en fonction de parametres et leurs chimeres dans des applications therapeutiques et diagnostiques
JP5465431B2 (ja) * 2005-07-27 2014-04-09 アルケミア オンコロジー ピーティーワイ リミテッド ヒアルロナンを用いる治療プロトコル
MY149606A (en) * 2005-09-07 2013-09-13 Alchemia Oncology Pty Ltd Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
JP5628544B2 (ja) * 2010-04-07 2014-11-19 株式会社豊田中央研究所 クロストリジウム・サーモセラム由来のタンパク質複合体を構築するためのタンパク質及びその利用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695542A (en) * 1983-10-04 1987-09-22 Dnax Research Institute Of Molecular And Cellular Biology, Inc. cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity
US4877729A (en) * 1986-07-14 1989-10-31 Genetics Institute, Inc. Recombinant DNA encoding novel family of primate hematopoietic growth factors
PT86381B (pt) * 1986-12-16 1990-11-20 Gist Brocades Nv Processo de clonagem molecular e de expressao de interleuquina-3 (il-3) humana
EP0275598B1 (fr) * 1986-12-16 1998-01-07 Gist-Brocades N.V. Clonage et expression moléculaire de IL-3 humain
WO1988005469A1 (fr) * 1987-01-20 1988-07-28 Immunex Corporation Proteines humaines il-3
OA09736A (en) * 1987-02-18 1993-11-30 Schering Biotech Corp "Human interleukin-3 and muteins thereof".
WO1990001039A1 (fr) * 1988-07-20 1990-02-08 Immunex Corporation Compositions d'interleukine-3 humaine non glycosylee

Also Published As

Publication number Publication date
DE69027031T2 (de) 1996-12-19
US5128450A (en) 1992-07-07
FI916077A0 (fi) 1991-12-20
JPH04506342A (ja) 1992-11-05
CA2033182A1 (fr) 1990-12-31
NO301482B1 (no) 1997-11-03
AU630207B2 (en) 1992-10-22
EP0482013B1 (fr) 1996-05-15
ATE138099T1 (de) 1996-06-15
NO915116L (no) 1992-02-28
EP0482013A1 (fr) 1992-04-29
WO1991000350A1 (fr) 1991-01-10
AU5821690A (en) 1991-01-17
NO915116D0 (no) 1991-12-27
DE69027031D1 (de) 1996-06-20
ES2090135T3 (es) 1996-10-16
FI916077A7 (fi) 1991-12-20

Similar Documents

Publication Publication Date Title
DK0482013T3 (da) Ikke-glycolyserede humant interleukin-3 analoge proteiner
AU6701890A (en) Process for the production of biologically active protein
IL85523A (en) Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it
SE7705432L (sv) Polypeptid och sett for dess framstellning
DE69129248D1 (de) Peptide mit Endothelin antagonistischer Aktivität, deren Herstellung und pharmazeutische Zusammensetzungen
YU174490A (sh) Novi estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje i primena tih jedinjenja
YU5396A (sh) Novi biološki aktivni proteini, njihove farmaceutske formulacije i postupak za njihovo dobijanje
MXPA02007931A (es) Analogos de nucleosido con base monociclica modificada con carboxamidina.
EP1440980A3 (fr) Analogues peptidiques de la protéine basique de la myéline humaine
PL316942A1 (en) Novel pharmaceutic compositions based on taxoides
FI893783A0 (fi) Menetelmä diabetes mellituksen hoitoon tarkoitetun farmaseuttisen valmisteen valmistamiseksi
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
PT89534A (pt) Processo para a preparacao de composicoes farmaceuticas anticoagulantes contendo como ingrediente activo proteina c ou proteina c activada combinada com heparina
ES2173858T3 (es) Analogos de huperzina a.
CA2208274A1 (fr) Analogues de peptide p227 et compositions pharmaceutiques comprenant ces analogues utilisees dans le traitement ou le diagnostic du diabete
HUP9700826A1 (hu) Peptikus fekély elleni gyógyászati készítmények
IT1299583B1 (it) Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica
ATE183775T1 (de) Cysteinfreie il-6 mutanten
DE69333412D1 (de) Übergangszustand-analoga des kokains, ihre verwendung zur herstellung von kataltischen antikörpern gegen kokain und verwendung derselben in diagnose und therapie
DE69636052D1 (de) Mpl-liganden analoga
DE59001121D1 (en) Antacidatabletten.
WO2004028457A3 (fr) Composition pharmaceutique pour administration amelioree de peptides derives de gp41 du vih et son utilisation en therapie
YU64192A (sh) Analozi insulina
ES2073063T3 (es) Formulaciones galenicas acuosas de eritropoyetina y su uso.